These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 3524431

  • 41. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.
    Bourgault AM, Lamothe F.
    J Antimicrob Chemother; 1986 May; 17(5):593-603. PubMed ID: 3636324
    [Abstract] [Full Text] [Related]

  • 42. Development of beta-lactamase inhibitors.
    Sutherland R.
    J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
    [Abstract] [Full Text] [Related]

  • 43. Susceptibility of ticarcillin-resistant gram-negative bacilli to different combinations of ticarcillin and clavulanic acid.
    Verbist L, Verhaegen J.
    J Antimicrob Chemother; 1986 May; 17 Suppl C():7-15. PubMed ID: 3636338
    [Abstract] [Full Text] [Related]

  • 44. Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid.
    Van der Auwera P, Duchateau V, Lambert C, Husson M, Kinzig M, Sörgel F.
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1860-8. PubMed ID: 8239597
    [Abstract] [Full Text] [Related]

  • 45. [Activity of ticarcillin combined with different concentrations of clavulanic acid on 137 Gram-negative bacilli resistant to ticarcillin].
    Aubert G, Dorche G, Frere A, Raby N, Denis M.
    Pathol Biol (Paris); 1987 May; 35(5):537-41. PubMed ID: 3302858
    [Abstract] [Full Text] [Related]

  • 46. Antistaphylococcal activity of amoxicillin and ticarcillin when combined with clavulanic acid. Evaluation of oxacillin-resistant and oxacillin-susceptible isolates.
    Barry AL.
    Diagn Microbiol Infect Dis; 1990 May; 13(5):357-61. PubMed ID: 2282775
    [Abstract] [Full Text] [Related]

  • 47. Beta-lactamase inhibition: therapeutic advances. Proceedings of a symposium. Fort Lauderdale, Florida, March 22-23, 1985.
    Am J Med; 1985 Nov 29; 79(5B):1-196. PubMed ID: 3878079
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
    Monteil H, Jehl F.
    Pathol Biol (Paris); 1987 Jun 29; 35(5 Pt 2):805-8. PubMed ID: 3309818
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Distribution of amoxicillin and clavulanic acid in infected animals and efficacy against experimental infections.
    Boon RJ, Beale AS, Comber KR, Pierce CV, Sutherland R.
    Antimicrob Agents Chemother; 1982 Sep 29; 22(3):369-75. PubMed ID: 7137980
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.